Happy to share our new preprint, led by Paul Dutchak! We explore RAPTOR-targeting ASOs to reduce dysregulated mTORC1 signaling in GATOR1-related epilepsy models, with relevance beyond epilepsy.
@chantellesephton.bsky.social
@chantellesephton.bsky.socialHappy to share our new preprint, led by Paul Dutchak! We explore RAPTOR-targeting ASOs to reduce dysregulated mTORC1 signaling in GATOR1-related epilepsy models, with relevance beyond epilepsy.
@alsnewstoday.bsky.socialA computer-based analysis of whole-blood samples identified 10 genes with altered activity that researchers say may have potential as biomarkers for diagnosing and tracking ALS.
đź”— Read more: https://bit.ly/4hD5DRF
@alsnewstoday.bsky.socialA targeted treatment for a rare genetic form of ALS has met its main goal in a Phase 3 trial.
Read more: https://bit.ly/3TpqLCD
@chemcenterbio.bsky.socialThe Holy Grail of Brain Repair: Which BDNF Booster Wins?
Analyze how Semax and elite BDNF peptides stimulate rapid neuroplasticity in research models for animals.
#peptdes #AlzheimersResearch #autismresearch #parkinsons #alsresearch
@alsnewstoday.bsky.socialA woman with a progressive motor neuron disease was able to generate her own words in real time using an investigational brain-computer interface: https://bit.ly/475unNs
#ALS #ALSResearch #BrainComputerInterface #ALSNewsToday #Bionews
@alsnewstoday.bsky.socialA very different approach to ALS treatment is now entering an early-stage clinical trial đź”— https://bit.ly/4xh5dGn
